Resting Energy Expenditure and the Effects of Muscle Wasting in Patients With Chronic Heart Failure: Results From the Studies Investigating Comorbidities Aggravating Heart Failure (SICA-HF)

被引:21
作者
Tacke, Matthias [1 ]
Ebner, Nicole [1 ]
Boschmann, Michael [2 ]
Jarius, Annett [2 ]
Valentova, Miroslava [1 ,3 ]
Fuelster, Susann [1 ]
Sandek, Anja [1 ]
Schomburg, Lutz [4 ]
Anker, Stefan D. [1 ]
Doehner, Wolfram [1 ,5 ]
von Haehling, Stephan [1 ,6 ]
机构
[1] Campus Virchow Klinikum, Charite Med Sch, Dept Cardiol, D-13353 Berlin, Germany
[2] Expt & Clin Res Ctr, Berlin, Germany
[3] Comenius Univ, Dept Internal Med 1, Bratislava, Slovakia
[4] Campus Virchow Klinikum, Charite Med Sch, Inst Expt Endocrinol, D-13353 Berlin, Germany
[5] Charite, Ctr Stroke Res Berlin, Berlin, Germany
[6] Charite, Ctr Cardiovasc Res, Berlin, Germany
关键词
Heart failure; muscle wasting; resting energy expenditure; glucagonlike peptide 1; BODY PROTEIN-METABOLISM; GLUCAGON-LIKE PEPTIDE-1; SKELETAL-MUSCLE; FAT OXIDATION; TASK-FORCE; SARCOPENIA; TURNOVER; CACHEXIA; DISEASE; MASS;
D O I
10.1016/j.jamda.2013.08.008
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives: Muscle wasting is common in patients with chronic heart failure (HF) and worsens functional status. Protein catabolism is characteristic of muscle wasting and contributes to resting energy expenditure (REE). Glucagonlike peptide 1 (GLP-1) is linked to REE in healthy individuals. We aimed to evaluate (1) whether REE is elevated in patients with HF with muscle wasting, and (2) whether basal GLP-1 levels are linked to REE in HF. Design: Cross-sectional study. Setting: Ambulatory patients with HF were recruited at the Charite Medical School, Campus VirchowKlinikum, Berlin, Germany. Participants: A total of 166 patients with HF and 27 healthy controls participating in the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF) were enrolled. GLP-1 was measured in 55 of these patients. Measurements: Body composition was measured by dual-energy X-ray absorptiometry (DEXA). Muscle wasting was defined as appendicular lean mass of at least 2 SDs below values of a healthy young reference group. REE was measured by indirect calorimetry. GLP-1 was assessed by ELISA. Results: Thirty-four of 166 patients (mean age 67.4 +/- 10.2 years, 77.7% male, NewYork Heart Association class 2.3 +/- 0.6) presented with muscle wasting. REE in controls and patients with muscle wasting was significantly lower than in patients without musclewasting (1579 +/- 289 and 1532 +/- 265 vs 1748 +/- 359 kcal/d, P=.018 and P=.001, respectively). REE normalized for fat-free mass (FFM) using the ratio method (REE/FFM) and analysis of covariance was not different (P=.23 and.71, respectively). GLP-1 did not significantly correlate with REE (P=.49), even not after controlling for FFM using multivariable regression (P=.15). Conclusions: Differences in REE are attributable to lower FFM. GLP-1 does not relate to REE in patients with HF, possibly because of HF-related effects on REE. Copyright (C) 2013 - American Medical Directors Association, Inc.
引用
收藏
页码:837 / 841
页数:5
相关论文
共 42 条
  • [1] Wasting as independent risk factor for mortality in chronic heart failure
    Anker, SD
    Ponikowski, P
    Varney, S
    Chua, TP
    Clark, AL
    WebbPeploe, KM
    Harrington, D
    Kox, WJ
    PooleWilson, PA
    Coats, AJS
    [J]. LANCET, 1997, 349 (9058) : 1050 - 1053
  • [2] Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors: Meta-Analysis and Systematic Review
    Aroda, Vanita R.
    Henry, Robert R.
    Han, Jenny
    Huang, Wenying
    DeYoung, Mary Beth
    Darsow, Tamara
    Hoogwerf, Byron J.
    [J]. CLINICAL THERAPEUTICS, 2012, 34 (06) : 1247 - 1258
  • [3] WHOLE-BODY PROTEIN-TURNOVER AND RESTING METABOLIC-RATE IN HOMOZYGOUS SICKLE-CELL DISEASE
    BADALOO, A
    JACKSON, AA
    JAHOOR, F
    [J]. CLINICAL SCIENCE, 1989, 77 (01) : 93 - 97
  • [4] Epidemiology of sarcopenia among the elderly in New Mexico
    Baumgartner, RN
    Koehler, KM
    Gallagher, D
    Romero, L
    Heymsfield, SB
    Ross, RR
    Garry, PJ
    Lindeman, RD
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1998, 147 (08) : 755 - 763
  • [5] Bradley DP, 2012, APPL PHYSIOL NUTR ME, V37, P893, DOI [10.1139/h2012-068, 10.1139/H2012-068]
  • [6] Skeletal muscle protein metabolism in human heart failure
    Callahan, Damien M.
    Toth, Michael J.
    [J]. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2013, 16 (01) : 66 - 71
  • [7] Research on cachexia, sarcopenia and skeletal muscle in cardiology
    Coats, Andrew J. S.
    [J]. JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2012, 3 (04) : 219 - 223
  • [8] Molecular and cellular mechanisms of skeletal muscle atrophy: an update
    Fanzani, Alessandro
    Conraads, Viviane M.
    Penna, Fabio
    Martinet, Wim
    [J]. JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2012, 3 (03) : 163 - 179
  • [9] THE THEORETICAL BASES OF INDIRECT CALORIMETRY - A REVIEW
    FERRANNINI, E
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1988, 37 (03): : 287 - 301
  • [10] Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF)
    Fuelster, Susann
    Tacke, Matthias
    Sandek, Anja
    Ebner, Nicole
    Tschoepe, Carsten
    Doehner, Wolfram
    Anker, Stefan D.
    von Haehling, Stephan
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 (07) : 512 - 519